These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35772325)

  • 1. Intrathecal application of ethosuximide is highly efficient in suppressing seizures in a genetic model of absence epilepsy.
    Buschhoff AS; Scherließ R; de Mooij-van Malsen JG; Schiffelholz T; Stephani U; Wulff P
    Epilepsy Res; 2022 Aug; 184():106967. PubMed ID: 35772325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chronic treatment with sodium channel blocker lacosamide on early development of absence seizures in genetic absence epilepsy rats.
    Çarçak N; Karanfil C; Akat Ş; Akman Ö; Onat F
    Epilepsy Res; 2022 May; 182():106896. PubMed ID: 35286866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.
    Dezsi G; Ozturk E; Stanic D; Powell KL; Blumenfeld H; O'Brien TJ; Jones NC
    Epilepsia; 2013 Apr; 54(4):635-43. PubMed ID: 23464801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS).
    Gülhan Aker R; Tezcan K; Carçak N; Sakalli E; Akin D; Onat FY
    Epilepsy Res; 2010 Mar; 89(1):7-16. PubMed ID: 19939632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical-area specific block of genetically determined absence seizures by ethosuximide.
    Manning JP; Richards DA; Leresche N; Crunelli V; Bowery NG
    Neuroscience; 2004; 123(1):5-9. PubMed ID: 14667436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of unilateral- versus bilateral-onset spike-wave discharges to ethosuximide and carbamazepine in the fluid percussion injury rat model of traumatic brain injury.
    Tatum S; Smith ZZ; Taylor JA; Poulsen DJ; Dudek FE; Barth DS
    J Neurophysiol; 2021 Jun; 125(6):2166-2177. PubMed ID: 33949882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spike and wave discharges detection in genetic absence epilepsy rat from Strasbourg and patients with genetic generalized epilepsy.
    Li R; Millist L; Foster E; Yuan X; Guvenc U; Radfar M; Marendy P; Ni W; O'Brien TJ; Casillas-Espinosa PM
    Epilepsy Res; 2023 Aug; 194():107181. PubMed ID: 37364342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ethosuximide on amino acids in genetic absence epilepsy rat model.
    Terzioğlu B; Aypak C; Onat FY; Küçükibrahimoğlu E; Ozkaynakçi AE; Gören MZ
    J Pharmacol Sci; 2006 Mar; 100(3):227-33. PubMed ID: 16538026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosuximide converts ictogenic neurons initiating absence seizures into normal neurons in a genetic model.
    Polack PO; Charpier S
    Epilepsia; 2009 Jul; 50(7):1816-20. PubMed ID: 19260940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAER-101, a selective potentiator of α2- and α3-containing GABA
    MacLean A; Chappell AS; Kranzler J; Evrard A; Monchal H; Roucard C
    Drug Dev Res; 2024 Apr; 85(2):e22160. PubMed ID: 38380694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral energy metabolism in rats with genetic absence epilepsy is not correlated with the pharmacological increase or suppression of spike-wave discharges.
    Nehlig A; Vergnes M; Marescaux C; Boyet S
    Brain Res; 1993 Jul; 618(1):1-8. PubMed ID: 8402164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy.
    Richards DA; Manning JP; Barnes D; Rombola L; Bowery NG; Caccia S; Leresche N; Crunelli V
    Epilepsy Res; 2003 May; 54(2-3):97-107. PubMed ID: 12837561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges.
    Chen SD; Yeh KH; Huang YH; Shaw FZ
    Epilepsia; 2011 Jul; 52(7):1311-8. PubMed ID: 21729038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of caffeine and adenosine receptor ligands on the expression of spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS).
    Germé K; Faure JB; Koning E; Nehlig A
    Epilepsy Res; 2015 Feb; 110():105-14. PubMed ID: 25616462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg.
    Powell KL; Tang H; Ng C; Guillemain I; Dieuset G; Dezsi G; Çarçak N; Onat F; Martin B; O'Brien TJ; Depaulis A; Jones NC
    Epilepsia; 2014 Dec; 55(12):1959-68. PubMed ID: 25377760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.
    Russo E; Citraro R; Scicchitano F; De Fazio S; Perrotta I; Di Paola ED; Constanti A; De Sarro G
    Epilepsia; 2011 Jul; 52(7):1341-50. PubMed ID: 21635238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect of Rho-kinase inhibitors Y-27632 and fasudil on spike-and-wave discharges in genetic absence epilepsy rats from Strasbourg (GAERS).
    Çarçak N; Yavuz M; Eryiğit Karamahmutoğlu T; Kurt AH; Urhan Küçük M; Onat FY; Büyükafsar K
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1275-1283. PubMed ID: 30073384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS.
    Rigoulot MA; Boehrer A; Nehlig A
    Epilepsia; 2003 Jan; 44(1):14-9. PubMed ID: 12581224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms.
    Sarkisova KY; Kuznetsova GD; Kulikov MA; van Luijtelaar G
    Epilepsia; 2010 Jan; 51(1):146-60. PubMed ID: 19674046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of absence seizures and changes in serotonergic and dopaminergic neurotransmission by nigrostriatal pathway degeneration in genetic absence epilepsy rats.
    Tugba EK; Medine GIO; Ozlem A; Deniz K; Filiz OY
    Pharmacol Biochem Behav; 2022 Feb; 213():173317. PubMed ID: 34974062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.